Switching from natalizumab to ocrelizumab in patients with multiple sclerosis. Levin SN, Ezuma C, Levine L, Vargas WS, et al. Mult Scler 2020 Jun 19:1352458520927631. doi: 10.1177/1352458520927631.

Read + Share

Amedeo Smart

Independent Medical Education

Levin SN, Ezuma C, Levine L, Vargas WS, et al. Switching from natalizumab to ocrelizumab in patients with multiple sclerosis. Mult Scler 2020 Jun 19:1352458520927631. doi: 10.1177/1352458520927631.
PMID: 32552363